{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:12:16Z","timestamp":1774084336409,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuro-Oncol"],"published-print":{"date-parts":[[1993]]},"DOI":"10.1007\/bf01054276","type":"journal-article","created":{"date-parts":[[2005,1,31]],"date-time":"2005-01-31T11:52:51Z","timestamp":1107172371000},"page":"71-79","source":"Crossref","is-referenced-by-count":20,"title":["Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors"],"prefix":"10.1007","volume":"17","author":[{"given":"David J.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zvonimir","family":"Grahovac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Hugenholtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasco","family":"DaSilva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brien","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Belanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neville","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0305-7372(89)90007-8","volume":"16","author":"DJ Stewart","year":"1989","unstructured":"Stewart DJ: The role of chemotherapy in the treatment of gliomas in adults. Cancer Treat Rev 16: 129?160, 1989","journal-title":"Cancer Treat Rev"},{"key":"CR2","first-page":"20","volume":"3","author":"DJ Stewart","year":"1989","unstructured":"Stewart DJ: Pros and cons of intra-arterial chemotherapy. Oncology 3: 20?26, 1989","journal-title":"Oncology"},{"key":"CR3","first-page":"143","volume-title":"The Neurological Complications of Cancer Treatment","author":"DJ Stewart","year":"1991","unstructured":"Stewart DJ: Intraarterial chemotherapy of primary and metastatic brain tumors. In: Rottenberg DA (ed) The Neurological Complications of Cancer Treatment. Butterworth-Heinemann, Boston 143?170, 1991"},{"key":"CR4","first-page":"69","volume":"6","author":"WR Shapiro","year":"1987","unstructured":"Shapiro WR, Green SB, Burger PC, Selker RG, VanGilder JD, Robertson JT, Mealey J, Ransohoff J, Mahaley MS: A randomized comparison of intraarterial vs intravenous BCNU for patients with malignant glioma: Interim analysis demonstrating lack of efficacy for IA BCNU. Proc Am Soc Clin Oncol 6: 69, 1987","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1227\/00006123-198412000-00010","volume":"15","author":"D J Stewart","year":"1984","unstructured":"Stewart D J, Grahovac Z, Benoit B, Addison D, Richard MT, Dennery J, Hugenholtz H, Russell N, Peterson E, Maroun JA, Vandenberg T, Hopkins HS: Intracarotid chemotherapy with a combination of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU), cis-diamminedichloroplatinum (Cisplatin), and 4?-O-demethyl-1-O-(4,6-O-2-thenylidene-?-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors. Neurosurgery 15: 828?833, 1984","journal-title":"Neurosurgery"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1227\/00006123-198708000-00013","volume":"21","author":"DJ Stewart","year":"1987","unstructured":"Stewart DJ, Grahovac Z, Hugenholtz H, Russell N, Richard M, Benoit B: Combined intraarterial and systemic chemotherapy for intracerebral tumors. Neurosurgery 21: 207?214, 1987","journal-title":"Neurosurgery"},{"issue":"Suppl 4","key":"CR7","first-page":"29","volume":"14","author":"AJ Coldman","year":"1987","unstructured":"Coldman AJ, Goldie JH: Impact of dose-intense chemotherapy on the development of permanent drug resistance. Sem Oncol 14 (Suppl 4): 29?33, 1987","journal-title":"Sem Oncol"},{"key":"CR8","first-page":"25","volume":"41","author":"JP Bergerat","year":"1981","unstructured":"Bergerat JP, Drewinko B, Corry P, Barlogie B, Ho DH: Synergistic lethal effect of cis-dichlrodiammineplatinum and 1-B-D-arabinofuranosylcytosine. Cancer Res 41: 25?30, 1981","journal-title":"Cancer Res"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00254528","volume":"7","author":"R Canetta","year":"1982","unstructured":"Canetta R, Hilgard P, Florentine S, Bedogni P, Lenaz L: Current development of podophyllotoxins. Cancer Chemother Pharmacol 7: 93?98, 1982","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR10","first-page":"149","volume":"1","author":"U Boghdan","year":"1983","unstructured":"Boghdan U: Chemosensitivity of malignant brain tumors: preliminary results. J Neuro-Oncol 1: 149?166, 1983","journal-title":"J Neuro-Oncol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00165155","volume":"2","author":"DJ Stewart","year":"1984","unstructured":"Stewart DJ, Richard M, Hugenholtz HN, Benoit B, Russell N, Dennery J, Peterson E, Maroun J: Cisplatin plus cytosine arabinoside in adults with malignant gliomas. J Neuro-Oncol 2: 29?34, 1984","journal-title":"J Neuro-Oncol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.51.4.701","volume":"51","author":"JS Meyer","year":"1975","unstructured":"Meyer JS, Itoh Y, Okamoto S, Welch KM, Matthew R, Ott EO, Sakaki S, Miyakawa Y, Chabi E, Ericsson AD: Circulatory and metabolic effects of glycerol infusion in patients with recent cerebral infarction. Circulation 51: 701?712, 1975","journal-title":"Circulation"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3171\/jns.1981.55.4.0550","volume":"55","author":"AM Burke","year":"1981","unstructured":"Burke AM, Quest DO, Chien S, Cerri C: The effects of mannitol on blood viscosity. J Neurosurg 55: 550?553, 1981","journal-title":"J Neurosurg"},{"key":"CR14","first-page":"777","volume":"59","author":"KB Bischoff","year":"1975","unstructured":"Bischoff KB: Some fundamental considerations of the applications of pharmacokinetics to cancer chemotherapy. Cancer Chemother Rep 59: 777?793, 1975","journal-title":"Cancer Chemother Rep"},{"key":"CR15","first-page":"315","volume":"2","author":"DJ Stewart","year":"1984","unstructured":"Stewart DJ, Richard MT, Hugenholtz H, Dennery J, Nundy D, Prior J, Montpetit V, Hopkins HS: Penetration of teniposide (VM-26) into human intracerebral tumors: preliminary observations on the effect of tumor type, rate of drug infusion, and prior treatment with amphotericin-B or oral glycerol. J Neuro-Oncol 2: 315?324, 1984","journal-title":"J Neuro-Oncol"},{"key":"CR16","unstructured":"Villemure JG: Personal communication"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00151229","volume":"5","author":"DJ Stewart","year":"1987","unstructured":"Stewart DJ, Grahovac Z, Russell NA, Hugenholtz H, Gupta S, Benoit BC, Richard MT, Maroun JA, Hopkins HS, Locke L: Phase I study of intracarotid PCNU. J Neuro-Oncol 5: 245?250, 1987","journal-title":"J Neuro-Oncol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00000421-198710000-00013","volume":"10","author":"DJ Stewart","year":"1987","unstructured":"Stewart DJ, Grahovac Z, Hugenholtz H, Russell NA, Richard MT, Benoit B, Riding MD, Danjoux C, Maroun JA: Intraarterial mitomycin-C for recurrent brain metastases. Am J Clin Oncol 10: 432?436, 1987","journal-title":"Am J Clin Oncol"},{"key":"CR19","first-page":"512","volume":"30","author":"DJ Stewart","year":"1992","unstructured":"Stewart DJ, Belanger JMEG, Grahovac Z, Curuvija S, Gionet LR, Aitken SE, Hugenholtz H, Benoit B, DaSilva V: Phase I study of intracarotid administration of carboplatin. Neurosurg. 30: 512?517, 1992","journal-title":"Neurosurg."},{"key":"CR20","first-page":"519","volume":"61","author":"JD Fenstermacher","year":"1977","unstructured":"Fenstermacher JD, Cowles AK: Theoretic limitations of intracarotid infusions in brain tumor chemotherapy. Cancer Treat Rep 61: 519?526, 1977","journal-title":"Cancer Treat Rep"},{"key":"CR21","first-page":"388","volume":"47","author":"B Teicher","year":"1987","unstructured":"Teicher B, Holden S, Kelley M, Shea T, Cucchi Q, Rosowsky A, Henner W, Frei E III: Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum (II). Cancer Res 47: 388?393, 1987","journal-title":"Cancer Res"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00254568","volume":"19","author":"P Andrews","year":"1987","unstructured":"Andrews P, Murphy MP, Howell SB,et al.: Metallothioneinmediated cisplatin resistance in human ovarian carcinoma cells. Cancer Chemotherapy Pharmacol 19: 149?154, 1987","journal-title":"Cancer Chemotherapy Pharmacol"},{"key":"CR23","first-page":"281","volume":"28","author":"S Kelley","year":"1987","unstructured":"Kelley S, Lazo J: Metallothionein (MT) content and antineoplastic drug resistance. (Abstr) Proc Am Assoc Cancer Res 28: 281, 1987","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR24","first-page":"1453","volume":"46","author":"MK Spigelman","year":"1986","unstructured":"Spigelman MK, Zappulla RA, Strauchen JA, Feuer EJ, Johnson J, Goldsmith SJ, Malis LI, Holland JF: Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae. Cancer Res 46: 1453?1457, 1986","journal-title":"Cancer Res"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ana.410140310","volume":"14","author":"EA Neuwelt","year":"1983","unstructured":"Neuwelt EA, Glasberg M, Frenkel E,et al.: Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies. Ann Neurol 14: 316?324, 1983","journal-title":"Ann Neurol"},{"key":"CR26","first-page":"97","volume-title":"Neurological Complications of Cancer Treatment","author":"PC Phillips","year":"1991","unstructured":"Phillips PC, Reinhard CS: Antipyrimidine neurotoxicity: cytosine arabinoside and 5-fluorouracil. In: Rottenberg DA (ed) Neurological Complications of Cancer Treatment. Butterworth-Heinemann, Boston 97?114, 1991"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3171\/jns.1986.64.5.0754","volume":"64","author":"JJ Jafar","year":"1986","unstructured":"Jafar JJ, Johns LM, Mullan SF: The effect of mannitol on cerebral blood flow. J Neurosurg 64: 754?759, 1986","journal-title":"J Neurosurg"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3171\/jns.1985.63.1.0043","volume":"63","author":"AD Mendelow","year":"1985","unstructured":"Mendelow AD, Teasdale GM, Russell T, Flood J, Patterson J, Murray GD: Effect of mannitol on cerebral blood flow and cerebral perfusion pressure in human head injury. J Neurosurg 63: 43?48, 1985","journal-title":"J Neurosurg"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01054276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01054276\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01054276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:50:36Z","timestamp":1556585436000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01054276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993]]}},"alternative-id":["BF01054276"],"URL":"https:\/\/doi.org\/10.1007\/bf01054276","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993]]}}}